Effect of pharmaceutical excipients on the permeability of P-glycoprotein substrate

被引:16
作者
Al-Mohizea, A. M. [1 ]
Zawaneh, F. [1 ]
Alam, M. A. [1 ]
Al-Jenoobi, F. I. [1 ]
El-Maghraby, G. M. [2 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia
[2] Tanta Univ, Coll Pharm, Dept Pharmaceut, Tanta, Egypt
关键词
Domperidone; P-glycoprotein; Efflux transport; Bioavailability; Everted sac; EVERTED GUT SAC; IN-VITRO; ORAL BIOAVAILABILITY; DRUG ABSORPTION; DOMPERIDONE; EFFLUX; EXPRESSION; INTESTINE; PHARMACOKINETICS; TRANSPORTER;
D O I
10.1016/S1773-2247(14)50093-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Present investigation evaluated permeability enhancing potential of pharmaceutical excipients (HPMC, PVP, Tween-80, Cremophor EL, Cremophor RH40,Transcutol, Labrasol and pluronics F-68) on the intestinal permeability of a P-glycoprotein substrate (domperidone). Everted and non-everted rat gut sacs were used for permeability studies. The investigation revealed that serosal to mucosal (S-M) transport of domperidone was greater than the mucosal to serosal (M-S) transport, which indicates that net movement of domperidone was towards lumen. Further, it was observed that S-M flux of domperidone was reduced by surfactant such as Tweett-80, Cremophor EL, Cremophor RH40, Transcutol, Labrasol and pluronics F-68. Pluronics F-68 showed inhibitory effect at higher concentration (0.8 % w/v), but no significant inhibition was observed at lower concentrations. Polymers like HPMC and PVP did not produce any remarkable effect on the permeability of domperidone. The findings suggested that some of the excipients may be used to increase the permeability and absorption of P-gp substrates. However, their role should be confirmed at molecular level and clinical relevance of these findings should be evaluated.
引用
收藏
页码:491 / 495
页数:5
相关论文
共 36 条
[1]   Making a case for domperidone in the treatment of gastrointestinal motility disorders [J].
Ahmad, Naveed ;
Keith-Ferris, Jeanne ;
Gooden, Elizabeth ;
Abell, Thomas .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (06) :571-576
[2]  
Al-Mohizea Abdullah M, 2010, Saudi Pharm J, V18, P97, DOI 10.1016/j.jsps.2010.02.005
[3]   Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates [J].
Alam, Mohd Aftab ;
Ali, Raisuddin ;
Al-Jenoobi, Fahad Ibrahim ;
Al-Mohizea, Abdullah M. .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (11) :1419-1440
[4]   Everted gut sac model as a tool in pharmaceutical research: limitations and applications [J].
Alam, Mohd Aftab ;
Al-Jenoobi, Fahad Ibrahim ;
Al-mohizea, Abdullah M. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (03) :326-336
[5]   Current methodologies used for evaluation of intestinal permeability and absorption [J].
Balimane, PV ;
Chong, SH ;
Morrison, RA .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :301-312
[6]  
Bamburowicz-Klimkowska M, 2007, PHARMACOL REP, V59, P752
[7]   Effects of monoglycerides on P-glycoprotein: Modulation of the activity and expression in Caco-2 cell monolayers [J].
Barta, Cheri A. ;
Sachs-Barrable, Kristina ;
Feng, Florina ;
Wasan, Kishor M. .
MOLECULAR PHARMACEUTICS, 2008, 5 (05) :863-875
[8]   The improved everted gut sac: a simple method to study intestinal P-glycoprotein [J].
Barthe, L ;
Bessouet, M ;
Woodley, JF ;
Houin, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 173 (1-2) :255-258
[9]   Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models [J].
Berggren, S ;
Hoogstraate, J ;
Fagerholm, U ;
Lennernäs, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (04) :553-560
[10]   P-glycoprotein and surfactants: Effect on intestinal talinolol absorption [J].
Bogman, K ;
Zysset, Y ;
Degen, L ;
Hopfgartner, G ;
Gutmann, H ;
Alsenz, J ;
Drewe, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) :24-32